.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

US Army
UBS
Queensland Health
Colorcon
Boehringer Ingelheim
Moodys
Julphar
Argus Health
Fish and Richardson
Baxter

Generated: September 22, 2017

DrugPatentWatch Database Preview

Esomeprazole sodium - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for esomeprazole sodium and what is the scope of esomeprazole sodium freedom to operate?

Esomeprazole sodium
is the generic ingredient in two branded drugs marketed by Aurobindo Pharma Ltd, Accord Hlthcare, Deva Holding As, Sun Pharma Global, Mylan Labs Ltd, and Astrazeneca Pharms, and is included in six NDAs. Additional information is available in the individual branded drug profile pages.

There are sixty-seven drug master file entries for esomeprazole sodium. Seven suppliers are listed for this compound.

Summary for Generic Name: esomeprazole sodium

Tradenames:2
Patents:0
Applicants:6
NDAs:6
Drug Master File Entries: see list67
Suppliers / Packagers: see list7
Bulk Api Vendors: see list204
Clinical Trials: see list2,622
Patent Applications: see list5,960
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:esomeprazole sodium at DailyMed

Pharmacology for Ingredient: esomeprazole sodium

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharma Global
ESOMEPRAZOLE SODIUM
esomeprazole sodium
INJECTABLE;INTRAVENOUS200882-002Mar 18, 2013APRXNoNo► Subscribe► Subscribe► Subscribe
Aurobindo Pharma Ltd
ESOMEPRAZOLE SODIUM
esomeprazole sodium
INJECTABLE;INTRAVENOUS204657-001Aug 10, 2016APRXNoYes► Subscribe► Subscribe► Subscribe
Mylan Labs Ltd
ESOMEPRAZOLE SODIUM
esomeprazole sodium
INJECTABLE;INTRAVENOUS202686-001May 17, 2017APRXNoNo► Subscribe► Subscribe► Subscribe
Astrazeneca Pharms
NEXIUM IV
esomeprazole sodium
INJECTABLE;INTRAVENOUS021689-002Mar 31, 2005APRXYesYes► Subscribe► Subscribe► Subscribe
Accord Hlthcare
ESOMEPRAZOLE SODIUM
esomeprazole sodium
INJECTABLE;INTRAVENOUS205379-001Sep 25, 2015APRXNoNo► Subscribe► Subscribe► Subscribe
Astrazeneca Pharms
NEXIUM IV
esomeprazole sodium
INJECTABLE;INTRAVENOUS021689-001Mar 31, 2005DISCNYesNo► Subscribe► Subscribe► Subscribe
Mylan Labs Ltd
ESOMEPRAZOLE SODIUM
esomeprazole sodium
INJECTABLE;INTRAVENOUS202686-002May 17, 2017APRXNoNo► Subscribe► Subscribe► Subscribe
Aurobindo Pharma Ltd
ESOMEPRAZOLE SODIUM
esomeprazole sodium
INJECTABLE;INTRAVENOUS204657-002Aug 10, 2016APRXNoNo► Subscribe► Subscribe► Subscribe
Deva Holding As
ESOMEPRAZOLE SODIUM
esomeprazole sodium
INJECTABLE;INTRAVENOUS207181-001Mar 6, 2017APRXNoNo► Subscribe► Subscribe► Subscribe
Sun Pharma Global
ESOMEPRAZOLE SODIUM
esomeprazole sodium
INJECTABLE;INTRAVENOUS200882-001Mar 18, 2013APRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: esomeprazole sodium

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Astrazeneca Pharms
NEXIUM IV
esomeprazole sodium
INJECTABLE;INTRAVENOUS021689-001Mar 31, 2005► Subscribe► Subscribe
Astrazeneca Pharms
NEXIUM IV
esomeprazole sodium
INJECTABLE;INTRAVENOUS021689-002Mar 31, 2005► Subscribe► Subscribe
Astrazeneca Pharms
NEXIUM IV
esomeprazole sodium
INJECTABLE;INTRAVENOUS021689-001Mar 31, 2005► Subscribe► Subscribe
Astrazeneca Pharms
NEXIUM IV
esomeprazole sodium
INJECTABLE;INTRAVENOUS021689-002Mar 31, 2005► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Citi
Cipla
Harvard Business School
UBS
QuintilesIMS
Moodys
Johnson and Johnson
Express Scripts
US Department of Justice
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot